Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards
May 05, 2025 19:30 HKT |  |
|
Azurite Medical and Wellness Launches Revolutionary Luxury Surgical Retreat Concept in Global Medical Tourism Market
Apr 29, 2025 02:09 HKT |  |
|
Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia
Apr 25, 2025 15:49 HKT |  |
|
HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025
Apr 24, 2025 18:43 HKT |  |
|
君圣泰医药三项创新研究成果即将亮相2025欧肝会(EASL)
Apr 24, 2025 18:35 HKT | |
|
Everest Medicines Announces Approval of 'B' Marker Removal from Company's Stock Code by the Hong Kong Stock Exchange
Apr 22, 2025 10:16 HKT | |
|
雲頂新耀「摘B」成功 盈利能力與創新價值獲雙重驗證
Apr 22, 2025 10:12 HKT | |
|
云顶新耀"摘B"成功 盈利能力与创新价值获双重验证
Apr 22, 2025 10:11 HKT | |
|
CIRC: Attained a New High in Fiscal Year 2024
Apr 22, 2025 09:52 HKT | |
|
中國同輻2024財年再創新高
Apr 22, 2025 09:25 HKT | |
|
中国同辐2024财年再创新高
Apr 22, 2025 09:16 HKT | |
|
金嗓子集團：業績持續增長 多維驅動長期價值釋放
Apr 18, 2025 10:10 HKT | |
|
金嗓子集团：业绩持续增长 多维驱动长期价值释放
Apr 18, 2025 10:04 HKT | |
|
熊去氧胆小檗碱（HTD1801）一药多效 即将进入商业化新纪元
Apr 15, 2025 08:10 HKT | |
|
熊去氧膽小檗堿（HTD1801）一藥多效 即將進入商業化新紀元
Apr 15, 2025 08:10 HKT | |
|
Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA
Apr 15, 2025 08:00 HKT | |
|
健倍苗苗完成收購天喜堂90%股權
Apr 03, 2025 17:30 HKT |  |
|
JBM Healthcare Completes Acquisition of 90% Interest in Tin Hee Tong
Apr 03, 2025 17:30 HKT | |
|
健倍苗苗完成收购天喜堂90%股权
Apr 03, 2025 17:21 HKT | |
|
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025
Apr 03, 2025 17:00 HKT |  |
|
|
<< Previous
Next >>
|